2024 Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine

NOTICE: Virtual registration will CLOSE on Friday, June 7, 2024. On-site, walk-in registration is still available on day-of.

The Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine (AIPM), co-sponsored by Pfizer Inc, Northeastern University and the American Statistical Association (ASA), is intended to provide a forum for major stakeholders to have a dialogue on pertinent issues that have policy implications for proper implementation of this emerging technology.

This event is designed to serve as a platform for:

• Statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine
• Fostering collaboration among industry, academia, regulatory agencies, and professional associations
• Discussing policy implications for proper implementation of AI in promoting public health

The theme of the 2024 AIPM Symposiums is Generative AI in Medical Research & Development: Hype or Reality?

Registration for this event includes complementary registration for the Evening Reception hosted by Northeastern University.

Host or Publisher American Statistical Association